Track open bid opportunities, contracts, public meetings, and key contacts for Alaska Board of Pharmacy.
Key metrics and characteristics
City
The city where this buyer is located.
Juneau
Zip Code
Postal code for this buyer's location.
99811
Propensity to Spend
How likely this buyer is to spend on new technology based on operating budget trends.
AI Adoption Score
How likely this buyer is to adopt new AI technologies.
Startup Friendliness
How often this buyer champions startups and early adoption.
Latest Budget Year
Unlock to view
Operating Budget
Unlock to view
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Procurement guidance and navigation tips.
These are suggested options, not confirmed memberships or past purchases. Our team can help confirm the right purchasing path for this agency.
Board meetings and strategic plans from Alaska Board of Pharmacy
The board discussed several items, including updates on the Prescription Drug Monitoring Program (PDMP) such as interstate data sharing and vendor reporting issues. Division updates included leadership changes, implementation of HB 195, regulatory reform under Administrative Order 360, and licensing renewal progress. Industry updates from the Alaska Pharmacy Association focused on the prescriptive authority bill, collaborative practice agreements, and funding for rural healthcare projects. Investigative reports were reviewed, and orders for voluntary surrender of licenses were approved. The board also addressed compounding inspection forms, the initiation of regulation projects to comply with HB 195 and AO 360, and identified a regulatory loophole concerning wholesale drug distributors and third-party logistics providers.
The board meeting focused on several key items, including the review and approval of the updated inspection report and multiple consent agreement orders for various investigation cases. The board reviewed disciplinary matrices and received updates on the Prescription Drug Monitoring Program and divisional administrative operations. Key discussions included legislative matters such as pharmacist prescription authority (SB 147/HB 195), opioid overdose drug prescription (HB 270), and the Controlled Substances Advisory Committee (SB 233), with the board resolving to submit letters of support for the latter two. The board also approved a regulatory reduction and revision plan in compliance with Administrative Order 360 and discussed the Rural Health Transformation Program. Several administrative agenda items concerning board appointments and delegations were tabled until the next meeting.
The board reviewed investigative reports and disciplinary cases, including consent agreement orders. Administrative updates focused on the renewal season, board vacancies, and the roles of the vice chairperson. Financial discussions included the fiscal year budget report and a fee change project. The board received industry updates regarding Medicaid dispensing fees, rural healthcare projects, and federal legislation. Significant attention was given to the regulation reduction project under Administrative Order 360, including forming a workgroup for regulation reform, discussing statutory matters, and establishing policies for pharmacy emergency closures. Additionally, the board approved self-inspection sheets and received an update on the Prescription Drug Monitoring Program.
Extracted from official board minutes, strategic plans, and video transcripts.
Track Alaska Board of Pharmacy meetings, strategic plans, and budget discussions before the public bid appears.
Early signals from meeting minutes and plans
Vendor mentions and competitor tracking
Decision timeline from discussion to RFP
Public-sector contacts connected to Alaska Board of Pharmacy.
Quotable insights from buyer leadership
